Integrating Current Evidence and Individualized Treatment Regimens Into Clinical Practice for Patients With Myeloproliferative Neoplasms

Gain expert insights on the latest evidence-based strategies and emerging therapies for the management of essential thrombocythemia, polycythemia vera, and myelofibrosis with a comprehensive educational program featuring an Interactive Decision Support Tool, on-demand podcasts, and commentaries.

Share

Program Content

Activities

PV Case Studies
Case Studies Illustrating the Latest Insights on Treating Polycythemia Vera
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 13, 2023

Expires: February 12, 2024

Treatment for ET
Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2023

Expires: February 22, 2024

Management of MF
Contemporary Topics in Treating Myelofibrosis: A Conversation Between Experts
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 07, 2023

Activities

Management of MF
Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 11, 2020

Treatment of PV
Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 11, 2023

Expires: January 10, 2024

Management of ET
Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2023

Expires: February 22, 2024

Activities

Expert Guidance for the Treatment of Myelofibrosis
Expert Guidance for the Treatment of Myelofibrosis
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: May 08, 2023

Activities

MPN Treatment
Integrating Current Evidence and Individualized Treatment Regimens Into Clinical Practice for Patients With MPNs
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2023

Expires: August 22, 2024

MPN Treatment
Individualizing Treatment for Patients With Myeloproliferative Neoplasms
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2023

Faculty

cover img faculity

Prithviraj Bose, MD

Professor
Department of Leukemia
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Andrew Kuykendall, MD

Assistant Member
Department of Malignant Hematology
H. Lee Moffitt Cancer Center
Tampa, Florida

cover img faculity

John Mascarenhas, MD

Director
Center of Excellence in Blood Cancers and Myeloid Disorders
Director
Adult Leukemia Program
Leader
Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Ruben A. Mesa, MD

President
Enterprise Cancer Service Line
Executive Director
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Enterprise Senior Vice President
Atrium Health
Vice Dean for Cancer Programs
Wake Forest University School of Medicine
Professor of Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina

cover img faculity

Raajit K. Rampal, MD, PhD

Associate Member
Director, MPN and Rare Hematologic Malignancies Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by educational grants from

GSK

Incyte Corporation

PharmaEssentia Corp